Several clinical studies have reported that patients with lung cancer had higher circulating chemerin concentrations than controls and/or that serum chemerin concentrations were positively associated with several clinical parameters including stage, lymph node infiltration, and distant metastasis (Table 1) [68,69,70,119]. This evidence concerns the gene RARRES2 and lung cancer.